369 related articles for article (PubMed ID: 19434850)
1. An investigation into the influence of counterion on the properties of some amorphous organic salts.
Towler CS; Li T; Wikström H; Remick DM; Sanchez-Felix MV; Taylor LS
Mol Pharm; 2008; 5(6):946-55. PubMed ID: 19434850
[TBL] [Abstract][Full Text] [Related]
2. Impact of the counterion on the solubility and physicochemical properties of salts of carboxylic acid drugs.
David SE; Timmins P; Conway BR
Drug Dev Ind Pharm; 2012 Jan; 38(1):93-103. PubMed ID: 22118222
[TBL] [Abstract][Full Text] [Related]
3. Effect of counterions on the properties of amorphous atorvastatin salts.
Sonje VM; Kumar L; Puri V; Kohli G; Kaushal AM; Bansal AK
Eur J Pharm Sci; 2011 Nov; 44(4):462-70. PubMed ID: 21907794
[TBL] [Abstract][Full Text] [Related]
4. An Examination of Water Vapor Sorption by Multicomponent Crystalline and Amorphous Solids and Its Effects on Their Solid-State Properties.
Newman A; Zografi G
J Pharm Sci; 2019 Mar; 108(3):1061-1080. PubMed ID: 30391302
[TBL] [Abstract][Full Text] [Related]
5. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids.
Morissette SL; Almarsson O; Peterson ML; Remenar JF; Read MJ; Lemmo AV; Ellis S; Cima MJ; Gardner CR
Adv Drug Deliv Rev; 2004 Feb; 56(3):275-300. PubMed ID: 14962582
[TBL] [Abstract][Full Text] [Related]
6. Analysis of relationships between solid-state properties, counterion, and developability of pharmaceutical salts.
Guerrieri P; Rumondor AC; Li T; Taylor LS
AAPS PharmSciTech; 2010 Sep; 11(3):1212-22. PubMed ID: 20680707
[TBL] [Abstract][Full Text] [Related]
7. Understanding the glass-forming ability of active pharmaceutical ingredients for designing supersaturating dosage forms.
Kawakami K; Usui T; Hattori M
J Pharm Sci; 2012 Sep; 101(9):3239-48. PubMed ID: 22531946
[TBL] [Abstract][Full Text] [Related]
8. Investigating the moisture sorption behavior of amorphous sucrose using a dynamic humidity generating instrument.
Yu X; Kappes SM; Bello-Perez LA; Schmidt SJ
J Food Sci; 2008 Jan; 73(1):E25-35. PubMed ID: 18211350
[TBL] [Abstract][Full Text] [Related]
9. Water-solid interactions. III. Effect of glass transition temperature, Tg, and processing on tensile strength of compacts of lactose and lactose/polyvinyl pyrrolidone.
Stubberud L; Arwidsson HG; Hjortsberg V; Graffner C
Pharm Dev Technol; 1996 Jul; 1(2):195-204. PubMed ID: 9552346
[TBL] [Abstract][Full Text] [Related]
10. The influence of aqueous content in small scale salt screening--improving hit rate for weakly basic, low solubility drugs.
Tarsa PB; Towler CS; Woollam G; Berghausen J
Eur J Pharm Sci; 2010 Sep; 41(1):23-30. PubMed ID: 20553863
[TBL] [Abstract][Full Text] [Related]
11. Effect of a counterion on the glass transition temperature (T(g)') during lyophilization of ganciclovir salt forms.
Kumar L; Baheti A; Bansal AK
Mol Pharm; 2011 Feb; 8(1):309-14. PubMed ID: 21133416
[TBL] [Abstract][Full Text] [Related]
12. A novel approach for analyzing glass-transition temperature vs. composition patterns: application to pharmaceutical compound+polymer systems.
Kalogeras IM
Eur J Pharm Sci; 2011 Apr; 42(5):470-83. PubMed ID: 21324354
[TBL] [Abstract][Full Text] [Related]
13. Trends in active pharmaceutical ingredient salt selection based on analysis of the Orange Book database.
Paulekuhn GS; Dressman JB; Saal C
J Med Chem; 2007 Dec; 50(26):6665-72. PubMed ID: 18052022
[TBL] [Abstract][Full Text] [Related]
14. Use of pharmaceutical salts and cocrystals to address the issue of poor solubility.
Elder DP; Holm R; Diego HL
Int J Pharm; 2013 Aug; 453(1):88-100. PubMed ID: 23182973
[TBL] [Abstract][Full Text] [Related]
15. Transformation of acidic poorly water soluble drugs into ionic liquids.
Balk A; Wiest J; Widmer T; Galli B; Holzgrabe U; Meinel L
Eur J Pharm Biopharm; 2015 Aug; 94():73-82. PubMed ID: 25976317
[TBL] [Abstract][Full Text] [Related]
16. Applicability of the one-step DVS method for the determination of amorphous amounts for further different hydrophilic and hydrophobic drugs.
Müller T; Scherließ R; Schiewe J; Smal R; Weiler C; Steckel H
Eur J Pharm Biopharm; 2015 Aug; 94():333-41. PubMed ID: 26079523
[TBL] [Abstract][Full Text] [Related]
17. Solubility of crystalline organic compounds in high and low molecular weight amorphous matrices above and below the glass transition by zero enthalpy extrapolation.
Amharar Y; Curtin V; Gallagher KH; Healy AM
Int J Pharm; 2014 Sep; 472(1-2):241-7. PubMed ID: 24968139
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of salt screening methodologies.
Fernández Casares A; Nap WM; Ten Figás G; Huizenga P; Groot R; Hoffmann M
J Pharm Pharmacol; 2015 Jun; 67(6):812-22. PubMed ID: 25683791
[TBL] [Abstract][Full Text] [Related]
19. Comparative physical, mechanical and crystallographic properties of a series of gemfibrozil salts.
David SE; Ramirez M; Timmins P; Conway BR
J Pharm Pharmacol; 2010 Nov; 62(11):1519-25. PubMed ID: 21039537
[TBL] [Abstract][Full Text] [Related]
20. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
Zahedi P; Lee PI
Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
